Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stockholm - Delayed Quote SEK

iZafe Group AB (publ) (IZAFE-B.ST)

Compare
0.2470
-0.0080
(-3.14%)
At close: April 4 at 4:34:52 PM GMT+2
Loading Chart for IZAFE-B.ST
  • Previous Close 0.2550
  • Open 0.2550
  • Bid 0.2480 x --
  • Ask 0.2500 x --
  • Day's Range 0.2470 - 0.2590
  • 52 Week Range 0.1700 - 0.2880
  • Volume 263,025
  • Avg. Volume 232,774
  • Market Cap (intraday) 79.469M
  • Beta (5Y Monthly) 0.35
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated medication dispenser that handles medication pouches, smart pillboxes, facilitates and enables independent medication, and reminds and alerts in the scheduled doses. It also offers Pilloxa, a platform that provides real-time insights and improved data quality to empower and motivate patients. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.

www.izafe.se

7

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IZAFE-B.ST

View More

Performance Overview: IZAFE-B.ST

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

IZAFE-B.ST
15.42%
OMX Stockholm 30 Index (^OMX)
7.89%

1-Year Return

IZAFE-B.ST
12.79%
OMX Stockholm 30 Index (^OMX)
9.30%

3-Year Return

IZAFE-B.ST
68.33%
OMX Stockholm 30 Index (^OMX)
7.06%

5-Year Return

IZAFE-B.ST
85.78%
OMX Stockholm 30 Index (^OMX)
62.84%

Compare To: IZAFE-B.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IZAFE-B.ST

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    79.47M

  • Enterprise Value

    83.90M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.56

  • Price/Book (mrq)

    8.17

  • Enterprise Value/Revenue

    10.55

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -257.84%

  • Return on Assets (ttm)

    -41.26%

  • Return on Equity (ttm)

    -116.92%

  • Revenue (ttm)

    7.95M

  • Net Income Avi to Common (ttm)

    -20.51M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.15M

  • Total Debt/Equity (mrq)

    67.68%

  • Levered Free Cash Flow (ttm)

    -4.21M

Research Analysis: IZAFE-B.ST

View More

Company Insights: IZAFE-B.ST

Research Reports: IZAFE-B.ST

View More

People Also Watch